Listen: Ensuring Participant Diversity in COVID-19 Vaccine Trials

Listen: Ensuring Participant Diversity in COVID-19 Vaccine Trials

Season: 2
| Episode: 1
Modern technology has the power to overcome clinical trial participation challenges.
Dr. Jim Kublin, Executive Director of Operation Programs, CoVPN

The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.

Podcast